Client Login

In the News

Tuesday, December 5, 2017

Philly jury delivers $28M hit to J&J and Bayer over blood thinner Xarelto

Johnson & Johnson and Bayer found responsible for a woman’s injuries tied to the drug Xarelto, hit with $28M verdict in the first loss at a trial over the medicine.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Monday, November 20, 2017

Johnson & Johnson Hit with $247 Million Verdict in Hip Implant Trial

A federal jury in Dallas ordered Johnson & Johnson to pay $247 million to six patients who were injured by defective Pinnacle hip implants.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, October 18, 2017

Congress Allied with Drug Company Lobbyists to Derail the DEA’s War on Opioids

Amid a targeted lobbying effort, Congress weakened the DEA’s ability to go after drug distributors, even as opioid-related deaths continue to rise.

 

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, September 27, 2017

FDA Safety Alert: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants

New FDA safety information shows the complications of treating addicted individuals.

 

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, September 27, 2017

Nearly Half Of Patients Who Stop Taking Opioids For Six Months Resume Use Later

According to researchers at Magellan Health in Scottsdale, over 50 percent of patients who quit opioids for six months will resume use sometime thereafter.

Author: Amy Schwarz
0 Comments
Article rating: No rating
Monday, September 11, 2017

Galena To Pay $7.5M To Settle Opioid Kickback Suit

Galena Biopharma Inc. has agreed to pay $7.55 million to settle allegations that it paid doctors kickbacks in exchange for prescribing its fentanyl-based drug Abstral,

Author: Amy Schwarz
0 Comments
Article rating: No rating
Monday, September 11, 2017

F.D.A. Accuses EpiPen Maker of Failing to Investigate Malfunctions

EpiPen maker failed to investigate product flaws associated with patient deaths, FDA says

Author: Amy Schwarz
0 Comments
Article rating: No rating
Friday, September 8, 2017

J&J unit ordered to pay $57.1M to Pa. woman in pelvic mesh suit

Johnson & Johnson subsidiary to pay $57.1 million in damages to a Pennsylvania woman in defective pelvic mesh case

Author: Amy Schwarz
0 Comments
Article rating: No rating
Wednesday, September 6, 2017

Novo Nordisk Settles U.S. Suit Over Victoza for $58.65 Million

Drug maker failed to warn doctors of cancer risk, U.S. says

Author: Amy Schwarz
0 Comments
Article rating: No rating
Tuesday, August 15, 2017

Drug Industry Faces ‘Tidal Wave’ of Litigation Over Opioid Crisis

US officials seek to raise funds to fight the country's addiction epidemic and punish those they accuse of fueling the crisis.

Author: Amy Schwarz
0 Comments
Article rating: No rating
RSS
12345